申请人:Novita Pharmaceuticals, Inc.
公开号:US10208043B2
公开(公告)日:2019-02-19
Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
提供了用于治疗有需要的受试者中由 fascin 活性介导的病症或紊乱的组合物和方法,该方法包括向受试者施用治疗有效量的至少一种式 I-a 至 I-n、II、II-a、II-b 或 III 中任何一种的化合物或其药学上可接受的盐。